Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02591212 · ClinicalTrials.gov registry record · NA
A Pilot of Bystander Training Programming in Sexual Violence and Subtance Abuse
A NA study, sponsored by University of Kentucky.
- Completed
- Registry status
- NA
- Development phase
- 427
- Enrollment target
NCT02591212: Completed NA study, sponsored by University of Kentucky.
NCT02591212 is a NA study that has completed, run by University of Kentucky. The registered enrollment target is 427 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02591212, a NA study, has completed, sponsored by University of Kentucky.
- COMPLETED
- Registry status
- NA
- Development phase
- 427 participants
- Enrollment target
Study Summary
The purpose of this randomized intervention pilot is to evaluate the relative efficacy of bystander training elements (delivery mode and integration of substance abuse prevention) among cohorts of incoming undergraduates at the University of Kentucky, a nationally recognized leader in addressing sexual violence through bystander intervention programming. Per university policy, all incoming undergraduates will participate in mandatory online training covering sexual violence awareness, bystander concepts, and alcohol use/abuse. Consenting students will be randomized to one of the following training conditions: 1. Green Dot Intensive Bystander Training (INT) or 2. Student Wellness Training (active control). Students in each condition will be followed for 9 months, one academic year.
Primary Outcome
The primary outcome for this study is bystanding behaviors as measured by the number of behaviors reported by students overall and by domain. Bystanding behaviors are measured through reports of actual behaviors. These primary bystanding behavior outcomes will be used to evaluate the relative efficacy of the intervention(s). As bystanding requires opportunity, these primary outcomes will be examined accounting for the presence of opportunity to bystand. The primary analysis will be the compariso
Interventions
- BEHAVIORAL Green Dot
- BEHAVIORAL Wellness Initiatives for Student Empowerment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 427 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT02591212 record still lists
NCT02591212 is an interventional study that assigns participants to a tested intervention. The registered 427 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 2 interventions - of which Green Dot is the first listed.
NCT02591212 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02591212 about?
NCT02591212 is a clinical study titled "A Pilot of Bystander Training Programming in Sexual Violence and Subtance Abuse". The purpose of this randomized intervention pilot is to evaluate the relative efficacy of bystander training elements (delivery mode and integration of substance abuse prevention) among cohorts of incoming undergraduates at the University of Kentucky, a nationally recognized leader in addressing sex...
What is the current status of trial NCT02591212?
This trial is currently completed. It is a NA study. The enrollment target is 427 participants. The study started on 2015-11. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02591212?
The interventions under investigation include: Green Dot (BEHAVIORAL), Wellness Initiatives for Student Empowerment (BEHAVIORAL).
Who is sponsoring clinical trial NCT02591212?
This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02591212's enrollment target sits among peer trials
427 236th of 2000 higher than 1,765 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05566431 · 428 participants · NA
Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics
- NCT05646316 · 428 participants · Phase 3
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
- NCT05797610 · 428 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
- NCT06073626 · 428 participants · NA
Addressing Genomic Disparities in Cancer Survivors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia